FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for labeling activated lymphocytes in vitro with a complex compound. Method involves incubation of activated lymphocytes with RFP 99mTc-THEOXYM in amount of 2 ml with activity of 350–500 MBq, with periodic shaking during 20 minutes, after incubation, in a test tube with cell mass phosphate-salt buffer is added and total volume is increased to 10 ml, then test tube is centrifuged for 5–6 minutes at 1,500–2,000 rpm, after that supernatant fluid is completely removed, labeled 99mTc-theoxyme cell conglomerate is resuspended in 1 ml of a phosphate-salt buffer. Viability of labeled activated lymphocytes in vitro by the disclosed method remains higher than 95 %.
EFFECT: ready cell preparation may be administered intraperitoneally paravertebrally at the level of vanes or in the lumbar region and examined pathways of labeled cell migration in vivo by SPECT/CT.
1 cl, 3 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INFLAMMATION FOCI IDENTIFICATION BY THE METHOD OF POLY-ORGANIC SCINTIGRAPHY | 2017 |
|
RU2648877C1 |
METHOD OF QUANTITATIVE ASSESSMENT OF DEGREE OF CELLULAR PREPARATION RETENTION WITHIN TARGET ORGAN WHEN INTRAORGAN ADMINISTRATION USING RADIONUCLIDE METHOD | 2022 |
|
RU2809526C2 |
USING RADIOPHARMACEUTICAL COMPOSITION USING LABELLED AUTOLOGOUS LEUKOCYTES TO VISUALIZE LOCAL RADIATION LESIONS BY SINGLE-PHOTON EMISSION TOMOGRAPHY | 2018 |
|
RU2708088C2 |
METHOD FOR RADIONUCLIDE DIAGNOSIS OF PROSTATE CANCER | 2021 |
|
RU2776234C1 |
METHOD FOR RADIONUCLIDE MARKING INTESTINE BACILLUS MICROORGANISM FOR SCINTIGRAPHIC INVESTIGATION | 2005 |
|
RU2290643C1 |
METHOD OF LABEL OF MONONUCLEAR CELLS OF RED BONE MARROW WITH HELP OF Tc-EXAMETAZIME | 2007 |
|
RU2343933C1 |
METHOD OF PREPARING REAGENT FOR PRODUCING TECHNETIUM-99m LABELLED DOXORUBICIN | 2014 |
|
RU2563134C1 |
COLON CANCER DIAGNOSIS METHOD | 2021 |
|
RU2755010C1 |
METHOD FOR ASSESSING THE EFFECTIVENESS OF CHEMOTHERAPY FOR MALIGNANT LYMPHOMAS | 2019 |
|
RU2700105C1 |
METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER | 2020 |
|
RU2751103C1 |
Authors
Dates
2019-12-09—Published
2019-09-12—Filed